JP2024073531A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024073531A5 JP2024073531A5 JP2024038103A JP2024038103A JP2024073531A5 JP 2024073531 A5 JP2024073531 A5 JP 2024073531A5 JP 2024038103 A JP2024038103 A JP 2024038103A JP 2024038103 A JP2024038103 A JP 2024038103A JP 2024073531 A5 JP2024073531 A5 JP 2024073531A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- polypeptide
- variable domain
- pichia host
- immunoglobulin single
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662294470P | 2016-02-12 | 2016-02-12 | |
| US62/294,470 | 2016-02-12 | ||
| PCT/EP2017/053034 WO2017137579A1 (en) | 2016-02-12 | 2017-02-10 | Method for the production of immunoglobulin single variable domains |
| JP2018542263A JP7540877B2 (ja) | 2016-02-12 | 2017-02-10 | 免疫グロブリン単一可変ドメインの生成方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018542263A Division JP7540877B2 (ja) | 2016-02-12 | 2017-02-10 | 免疫グロブリン単一可変ドメインの生成方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024073531A JP2024073531A (ja) | 2024-05-29 |
| JP2024073531A5 true JP2024073531A5 (https=) | 2024-11-11 |
| JP7849405B2 JP7849405B2 (ja) | 2026-04-21 |
Family
ID=58018106
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018542263A Active JP7540877B2 (ja) | 2016-02-12 | 2017-02-10 | 免疫グロブリン単一可変ドメインの生成方法 |
| JP2024038103A Active JP7849405B2 (ja) | 2016-02-12 | 2024-03-12 | 免疫グロブリン単一可変ドメインの生成方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018542263A Active JP7540877B2 (ja) | 2016-02-12 | 2017-02-10 | 免疫グロブリン単一可変ドメインの生成方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10975141B2 (https=) |
| EP (1) | EP3414268A1 (https=) |
| JP (2) | JP7540877B2 (https=) |
| CN (1) | CN108699151B (https=) |
| AU (2) | AU2017216864B2 (https=) |
| CA (1) | CA3014443A1 (https=) |
| WO (1) | WO2017137579A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2768984T3 (https=) * | 2015-11-12 | 2018-06-09 | ||
| JP7540877B2 (ja) | 2016-02-12 | 2024-08-27 | アブリンクス エン．ヴェー． | 免疫グロブリン単一可変ドメインの生成方法 |
| EP3778865A4 (en) | 2018-03-26 | 2021-12-22 | National University Corporation Kobe University | NEW CELL AND PROCESS FOR THE PRODUCTION OF A PROTEIN OF INTEREST USING IT |
| IL293561A (en) | 2019-12-06 | 2022-08-01 | Ablynx Nv | Polypeptides comprising immunoglobulin with one variable domain targeting TNFa and IL-23 |
| CN110964113B (zh) * | 2019-12-24 | 2021-09-03 | 北京纽安博生物技术有限公司 | 介导结合免疫球蛋白的单域抗体、由其构建的双功能抗体及其应用 |
| JP7714233B2 (ja) * | 2020-03-19 | 2025-07-29 | 国立大学法人神戸大学 | 内在性遺伝子の発現が増強された遺伝子組換え細胞の製造方法 |
| CN115397868A (zh) * | 2020-03-30 | 2022-11-25 | 埃博灵克斯股份有限公司 | 用于产生和纯化多价免疫球蛋白单可变域的方法 |
| FR3120865B1 (fr) | 2021-03-19 | 2025-02-28 | Univ Toulouse 3 Paul Sabatier | Molécule hybride comprenant un fragment Fc d’anticorps et au moins un peptide citrulliné dérivé de la fibrine, et ses utilisations |
| FR3120877B1 (fr) | 2021-03-19 | 2025-03-14 | Univ Toulouse 3 Paul Sabatier | Cellule immunitaire comprenant un récepteur Fc à sa surface, et sur lequel est greffé une molécule hybride comprenant un fragment Fc d’anticorps et au moins un peptide citrulliné dérivé de la fibrine, et ses utilisations |
| FR3120866B1 (fr) | 2021-03-19 | 2025-02-28 | Univ Toulouse 3 Paul Sabatier | Molécule hybride comprenant un peptide citrulliné dérivé de la fibrine et un anticorps ou fragment d’anticorps se liant à CD38 et/ou CD138, et ses utilisations |
| CN114920839B (zh) * | 2022-06-17 | 2023-03-10 | 天津大学 | 特异性结合il-23的纳米抗体及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007250735A1 (en) * | 2006-05-16 | 2007-11-22 | Daiichi Sankyo Company, Limited | Method for high-level secretory production of protein |
| EP2285833B1 (en) | 2008-05-16 | 2014-12-17 | Ablynx N.V. | AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME |
| AU2010243551B2 (en) | 2009-04-30 | 2015-03-26 | Ablynx Nv | Method for the production of domain antibodies |
| US8440456B2 (en) * | 2009-05-22 | 2013-05-14 | Vib, Vzw | Nucleic acids of Pichia pastoris and use thereof for recombinant production of proteins |
| WO2011161266A1 (en) | 2010-06-25 | 2011-12-29 | Ablynx Nv | Improved immunoglobulin single variable domains and constructs thereof directed against cxcr4 |
| CN103917560B (zh) * | 2011-03-28 | 2017-05-24 | 埃博灵克斯股份有限公司 | 双特异性抗‑cxcr7免疫球蛋白单可变结构域 |
| EP4707303A2 (en) | 2014-05-16 | 2026-03-11 | Ablynx NV | Improved immunoglobulin variable domains |
| JP7540877B2 (ja) | 2016-02-12 | 2024-08-27 | アブリンクス エン．ヴェー． | 免疫グロブリン単一可変ドメインの生成方法 |
-
2017
- 2017-02-10 JP JP2018542263A patent/JP7540877B2/ja active Active
- 2017-02-10 EP EP17704752.9A patent/EP3414268A1/en active Pending
- 2017-02-10 WO PCT/EP2017/053034 patent/WO2017137579A1/en not_active Ceased
- 2017-02-10 AU AU2017216864A patent/AU2017216864B2/en active Active
- 2017-02-10 US US16/076,314 patent/US10975141B2/en active Active
- 2017-02-10 CN CN201780010990.9A patent/CN108699151B/zh active Active
- 2017-02-10 CA CA3014443A patent/CA3014443A1/en active Pending
-
2020
- 2020-07-30 US US16/943,022 patent/US11851480B2/en active Active
-
2023
- 2023-09-19 AU AU2023233070A patent/AU2023233070A1/en not_active Abandoned
-
2024
- 2024-03-12 JP JP2024038103A patent/JP7849405B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024073531A5 (https=) | ||
| CN104302665B (zh) | 与新生儿Fc受体的结合增强的变体Fc多肽 | |
| TWI359028B (en) | Bivalent, bispecific antibodies | |
| JP2019531704A5 (https=) | ||
| CN114450406B (zh) | 一种断裂型内含肽、使用其的重组多肽的制备方法 | |
| JP5738294B2 (ja) | 抗ｖｅｇｆモノクローナル抗体およびその抗体を含む薬学的組成物 | |
| JP2009523459A5 (https=) | ||
| JP2012515556A5 (https=) | ||
| JP2020500510A5 (https=) | ||
| TW200932269A (en) | Bivalent, bispecific antibodies | |
| JP2025063183A5 (https=) | ||
| JP2022009816A5 (https=) | ||
| JP2023509390A5 (https=) | ||
| US12000839B2 (en) | Methods for characterizing disulfide bonds | |
| JP2024509910A5 (https=) | ||
| CN116964084A (zh) | 双特异性抗体 | |
| TW202423965A (zh) | 與新生兒fc受體的特定表位結合之多肽 | |
| WO2026012501A1 (zh) | 一种抗ngf单克隆抗体及其应用 | |
| CN117683134B (zh) | 一种抗sla i纳米抗体及应用 | |
| CN117343182A (zh) | 抗人tigit抗体或其功能性片段及其应用 | |
| US20220380440A1 (en) | Truncated multivalent multimers | |
| JP2024521987A5 (https=) | ||
| Mala et al. | Construction and sequencing analysis of scFv antibody fragment derived from monoclonal antibody against norfloxacin (Nor155) | |
| CN121712805A (zh) | Ch3结构域变体或包含该ch3结构域变体的双特异性抗体 | |
| EP4382166A1 (en) | Anti-pd-l1 nanobody and use thereof |